ICON Takes Over Chinese CRO
This article was originally published in PharmAsia News
Executive Summary
ICON plc, globally the fifth-largest clinical research organization, announced its acquisition of Beijing KendleWits Medical Consulting Co., Ltd., a CRO in China.